Aggressive Trend Trade 1HAggressive Trend Trade 1H
- short trend
+ volumed T1
+ support level
+ biggest volume 2Sp+
Daily Trend
+ long impulse
+ T2 level
+ support level
+ 1/2 correction"
Monthly CounterTrend
"- short balance
+ expanding ICE
+ support level
+ unsuccessful biggest volume manipulation"
Yearly Trend
"+ long
Key facts today
HSBC has revised its price target for Pfizer (PFE) to $26 from $27, while continuing to maintain a 'Buy' rating on the stock.
15,955.00
0.00 BRL
43.24 B BRL
343.01 B BRL
About Pfizer
Sector
Industry
CEO
Albert Bourla
Website
Headquarters
New York
Founded
1849
ISIN
BRPFIZBDR006
FIGI
BBG0017227L4
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
PFE - A GOOD DIVIDEND PLAY LONG TERMGood Morning,
I have been keeping an eye on PFE for awhile as I want to get it on a low to hold in my TFSA long term for dividend payments.
PFE created an initial support at level 21-21.50$. PFE continued to climb aggressively until seeing some rejection at the 24$ level. It dropped down to ret
PFE – Long Trade Setup !📈 🟢
Ticker: Pfizer, Inc. (NYSE: PFE)
Chart: 30-Min Timeframe
Pattern: Ascending triangle breakout continuation
🔹 Entry: $24.38 (breakout from consolidation + trendline support)
🔹 Stop-Loss: $24.01 (below ascending trendline)
🔹 Take Profits:
TP1: $24.89 – Gap-fill resistance zone
TP2: $25.55 – M
Pfizer Stock Chart Fibonacci Analysis 042925Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 22.7/61.80%
Chart time frame:D
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress: C
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
Tensions in the Pharma Sector and Signs of U.S. StagflationBy Ion Jauregui – Analyst at ActivTrades
The U.S. biopharmaceutical industry may soon face significant regulatory changes. According to sector sources, the Trump administration is evaluating a proposal to tie U.S. drug prices to the lowest prices available in other developed countries. This initiati
PFEAt the current price, I'm looking for a retest toward the daily target zone located on the chart. On 3/21 PFE announced news about dropping the decision to move forward with the weight loss drug. Since then, price dropped down in spike like fashion. After the big volume spike, on that date, volume c
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
P
PFE5588586
Pfizer Investment Enterprises Pte. Ltd. 4.65% 19-MAY-2025Yield to maturity
8.91%
Maturity date
May 19, 2025
P
PFE5588844
Pfizer Investment Enterprises Pte. Ltd. 5.34% 19-MAY-2063Yield to maturity
6.39%
Maturity date
May 19, 2063
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053Yield to maturity
6.26%
Maturity date
May 19, 2053
See all PFIZ34 bonds
Curated watchlists where PFIZ34 is featured.